Your browser doesn't support javascript.
loading
A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity (SU2C-SARC032).
Saif, Areeba; Verbus, Emily A; Sarvestani, Amber Leila; Teke, Martha E; Lambdin, Jacob; Hernandez, Jonathan M; Kirsch, David G.
Afiliación
  • Saif A; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Verbus EA; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Sarvestani AL; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Teke ME; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Lambdin J; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Hernandez JM; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. jonathan.hernandez@nih.gov.
  • Kirsch DG; Radiation Oncology, Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, USA. david.kirsch@duke.edu.
Ann Surg Oncol ; 30(2): 683-685, 2023 02.
Article en En | MEDLINE | ID: mdl-36396869

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Sarcoma / Neoplasias de los Tejidos Blandos / Oncología por Radiación Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Idioma: En Revista: Ann Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Sarcoma / Neoplasias de los Tejidos Blandos / Oncología por Radiación Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Idioma: En Revista: Ann Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article